Compare McKesson Corporation (MCK) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs ZIM Integrated Shipping Services Ltd — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while ZIM Integrated Shipping Services Ltd trades at $29.99 (market cap $3.65B). The key difference: McKesson Corporation is far larger — about 29.7× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays the higher dividend (20.16%). Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| MCK | ZIM | |
|---|---|---|
Market Cap | $108.46B | $3.65B |
Volume | 712,607 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $995.69 | $30.51 |
52-Week Low | $725.17 | $12.44 |
Typical Hold Time | 74 Days | 27 Days |
Enterprise Value | $115.00B | $7.32B |
Dividend Yield | 0.4% | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
ZIM trades at $30.26, up 0.9% on the day and near its 52-week high of $30.96. The technical outlook is bullish based on moving averages, though oscillators are neutral. Fundamentally, Q2 2026 earnings beat estimates with EPS of $0.53 versus an expected loss, driven by higher freight rates and volumes. Revenue for 2026 is projected at $6.4B with a net income margin of 2.15%. The stock appears undervalued with a P/S of 0.57 and P/B of 0.94. Recent news highlights a pending $35 per share acquisition offer from Hapag-Lloyd, subject to Israeli government approval.
The investment outlook is mixed. The potential acquisition at a premium offers upside, and strong transpacific rates support earnings. However, analyst sentiment is cautious with no buy ratings, and net cash flow remains negative. Key risks include deal uncertainty, geopolitical factors, and volatile shipping rates. The stock presents a speculative opportunity tied to merger prospects and cyclical industry conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
